Verbund AG (0NR1)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 65.68 |
|---|---|
| 52-week range | 54.25 – 68.03 |
| Return, 1 month / 3 months | +5.6% / +11.9% |
| Return, 1 year / 3 years | +5.1% / −12.6% |
| Trend | Uptrend |
| RSI (14) | 62 |
| Volatility (1 year) | 24.7% |
| Worst drawdown (1 year) | -18.6% |
| Average daily value traded | 0.76M EUR |
| Dividend yield | 3.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Verbund AG is an Austrian electricity company based in Vienna. It generates power mainly from hydroelectric stations on the Danube and Alpine rivers, and also operates thermal and other generation capacity. The company runs electricity transmission and distribution networks and supplies power to industrial, commercial and household customers, largely in Austria and Germany. It also trades electricity and provides energy-related services, and the Austrian state holds a controlling stake in the business.
Verbund AG trades under the code 0NR1 on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Verbund AG (0NR1) trades on the London Exchange in UK. It last closed at EUR 65.68 on 19 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 875 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 5.1% and over the last three months it rose 11.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.1% | ||
| From 52-week high | -1.9% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 11.9% | ||
| 6-month return | 7.3% | ||
| 12-month return, skipping the last month | -0.4% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.6% | ||
| Liquidity | 50 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.76M EUR | ||
| Zero-volume days | 1.7% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.3% |
|---|---|
| 1 month | +5.6% |
| 3 months | +11.9% |
| 6 months | +7.3% |
| 1 year | +5.1% |
| 3 years | −12.6% |
| 5 years | – |
Signals
| 50-day / 200-day average | 61.25 / 60.22 |
|---|---|
| Golden / death cross (60 days) | Golden, 9 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.78 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Apr 2026 | EUR 2.0000 |
| 6 May 2025 | EUR 2.8000 |
| 7 May 2024 | EUR 0.7500 |
| 2 May 2023 | EUR 2.4400 |
| 3 May 2022 | EUR 1.0500 |
| 27 Apr 2021 | EUR 0.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.